Accendra Health, Inc. ACH
0.71
(0.02)
(2.74%)
as of 25 Sep
- Market cap
- $59.2M
- P/E
- 0.0×
Follow ACH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 72.63% | (2,037.64%) | (1,755.61%) | (602.33%) |
+8 more TTM periods Free account |
|
| (9.65%) | (29.76%) | (30.97%) | (29.40%) | ||
ROIC |
1.58% | 1.19% | 1.31% | (10.17%) | |
Return on Tangible Assets |
162.35% | 279.71% | 769.45% | 1,797.67% | |
Average Days of Receivables |
16.56 | 13.94 | 12.67 | 95.70 | |
Free Cash Flow per Share |
(2.75) | (2.03) | (2.93) | (3.60) | |
Free Cash Flow |
(210.90) | (154.99) | (225.15) | (278.42) | |
Capital Expenditures |
(30.49) | (38.19) | (123.36) | (179.44) | |
Piotroski F-Score |
3.00 | 2.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(15.36%) | (5.91%) | (5.44%) | (5.76%) | |
Accounts Receivable Turnover |
16.73 | 7.94 | 17.58 | 1.79 | |
Accounts Payable Turnover |
4.11 | 1.67 | 4.07 | (0.35) | |
Inventory Turnover |
20.49 | 1.99 | 20.74 | (0.44) | |
Average Days of Payables |
88.18 | 93.21 | 90.11 | (427.82) | |
Days of Inventory on Hand |
18.33 | 16.23 | 18.45 | (80.40) | |
Tax Rate |
(0.04) | (0.07) | 0.01 | 0.07 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.14% | 39.04% | 38.65% | 111.03% | |
Share Based Compensation of Revenue |
0.40% | 0.42% | 0.47% | 1.90% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.60 | 0.11 | 0.09 | 0.07 | |
Depreciation/Fixed assets |
1.23 | 1.02 | 0.84 | 2.23 | |
Capex/Depreciation |
(0.12) | (0.16) | (0.57) | (0.31) | |
Revenue per Share |
34.52 | 35.53 | 35.92 | 10.00 | |
Operating CF per Share |
(2.35) | (1.53) | (1.32) | (1.28) | |
Capex per Share |
(0.40) | (0.50) | (1.60) | (2.32) | |
Capex to Sales |
0.01 | 0.01 | 0.04 | 0.23 | |
Net Profit Margin |
(11.41%) | (39.84%) | (39.85%) | (173.35%) |
Columns are period end dates